COREMEDICO ApS: Financial statements 2022
CVR: 30070534
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
COREMEDICO ApS (CVR 30070534) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -10,063 and a net result of DKK -62,624 compared with DKK -171,088 the year before. Equity in the 2022 report amounted to DKK 326,489. The solvency ratio was 32.3%.
- Gross Profit
- DKK -10,063
- Profit/Loss
- DKK -62,624
- Equity
- DKK 326,489
- Total Assets
- DKK 1,012,068
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -10 t. | -63 t. | 326 t. | 0 |
| 2021 | - | -20 t. | -171 t. | 389 t. | 0 |
| 2020 | - | 31 t. | -15 t. | 560 t. | 0 |
| 2019 | - | 76 t. | 1 t. | 576 t. | 0 |
| 2018 | - | 26 t. | -31 t. | -426 t. | 1 |
Official annual report
Keep an eye on COREMEDICO ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
COREMEDICO ApS has published its annual report for 2021. Gross profit came to DKK -19,814, and the net result was DKK -171,088.
About COREMEDICO ApS
COREMEDICO ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2006. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Kevin Hagemann Petersen. The company is owned by JOSARDI ApS. The company has 1 employee (2016). In 2025, the company reported a gross profit of DKK -71,962 and a net result of DKK -781,873 compared with DKK -774,332 the year before. Equity in the 2025 report amounted to DKK 1,278,734.